Allogeneic tumor enhancement by levamisole, a new immunostimulatory compound: studies on cell-mediated immunity and humoral antibody response.
D000276:Adjuvants, Immunologic / Q000494:pharmacology*; D000818:Animals; D000917:Antibody Formation / Q000187:drug effects*; D000936:Antigen-Antibody Complex; D003601:Cytotoxicity Tests, Immunologic; D004912:Erythrocytes / Q000276:immunology; D006084:Graft Rejection / Q000187:drug effects; D007111:Immunity, Cellular / Q000187:drug effects*; D007939:Leukemia L1210 / Q000097:blood / Q000276:immunology; D007942:Leukemia, Experimental / Q000097:blood / Q000276:immunology*; D007978:Levamisole / Q000494:pharmacology*; D008214:Lymphocytes / Q000276:immunology; D008297:Male; D051379:Mice; D008809:Mice, Inbred C3H; D009368:Neoplasm Transplantation; D012756:Sheep; D013154:Spleen / Q000276:immunology; D014184:Transplantation, Homologous
D000276:Adjuvants, Immunologic; D000936:Antigen-Antibody Complex; D007978:Levamisole